Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 8/10

vs
industry
vs
history
Cash to Debt 0.28
CMN's Cash to Debt is ranked lower than
78% of the 192 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.21 vs. CMN: 0.28 )
Ranked among companies with meaningful Cash to Debt only.
CMN' s 10-Year Cash to Debt Range
Min: 0.05  Med: 0.35 Max: No Debt
Current: 0.28
Equity to Asset 0.68
CMN's Equity to Asset is ranked higher than
67% of the 181 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.60 vs. CMN: 0.68 )
Ranked among companies with meaningful Equity to Asset only.
CMN' s 10-Year Equity to Asset Range
Min: 0.43  Med: 0.62 Max: 0.81
Current: 0.68
0.43
0.81
Interest Coverage 29.80
CMN's Interest Coverage is ranked lower than
53% of the 111 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 53.79 vs. CMN: 29.80 )
Ranked among companies with meaningful Interest Coverage only.
CMN' s 10-Year Interest Coverage Range
Min: 3.63  Med: 13.97 Max: 9999.99
Current: 29.8
3.63
9999.99
F-Score: 6
Z-Score: 8.97
M-Score: -2.45
WACC vs ROIC
13.53%
11.19%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating margin (%) 13.98
CMN's Operating margin (%) is ranked higher than
71% of the 189 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.48 vs. CMN: 13.98 )
Ranked among companies with meaningful Operating margin (%) only.
CMN' s 10-Year Operating margin (%) Range
Min: 4.03  Med: 10.44 Max: 14.87
Current: 13.98
4.03
14.87
Net-margin (%) 8.33
CMN's Net-margin (%) is ranked higher than
65% of the 189 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.54 vs. CMN: 8.33 )
Ranked among companies with meaningful Net-margin (%) only.
CMN' s 10-Year Net-margin (%) Range
Min: 1.34  Med: 6.35 Max: 12.33
Current: 8.33
1.34
12.33
ROE (%) 12.07
CMN's ROE (%) is ranked higher than
70% of the 182 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.29 vs. CMN: 12.07 )
Ranked among companies with meaningful ROE (%) only.
CMN' s 10-Year ROE (%) Range
Min: 5.37  Med: 12.40 Max: 22.36
Current: 12.07
5.37
22.36
ROA (%) 8.28
CMN's ROA (%) is ranked higher than
77% of the 193 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.43 vs. CMN: 8.28 )
Ranked among companies with meaningful ROA (%) only.
CMN' s 10-Year ROA (%) Range
Min: 3.2  Med: 8.28 Max: 15.4
Current: 8.28
3.2
15.4
ROC (Joel Greenblatt) (%) 54.34
CMN's ROC (Joel Greenblatt) (%) is ranked higher than
87% of the 191 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 11.56 vs. CMN: 54.34 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
CMN' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: 19.05  Med: 38.11 Max: 61.13
Current: 54.34
19.05
61.13
Revenue Growth (3Y)(%) 12.60
CMN's Revenue Growth (3Y)(%) is ranked higher than
81% of the 151 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.00 vs. CMN: 12.60 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
CMN' s 10-Year Revenue Growth (3Y)(%) Range
Min: 0.8  Med: 12.05 Max: 29.4
Current: 12.6
0.8
29.4
EBITDA Growth (3Y)(%) 24.50
CMN's EBITDA Growth (3Y)(%) is ranked higher than
78% of the 128 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.70 vs. CMN: 24.50 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
CMN' s 10-Year EBITDA Growth (3Y)(%) Range
Min: 1.2  Med: 18.50 Max: 40.8
Current: 24.5
1.2
40.8
EPS Growth (3Y)(%) 25.20
CMN's EPS Growth (3Y)(%) is ranked higher than
77% of the 126 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.70 vs. CMN: 25.20 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
CMN' s 10-Year EPS Growth (3Y)(%) Range
Min: -6.3  Med: 24.05 Max: 46.5
Current: 25.2
-6.3
46.5
» CMN's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q3 2014

CMN Guru Trades in Q3 2014

RS Investment Management Sold Out
Mario Gabelli 389,748 sh (-1.57%)
Joel Greenblatt 17,444 sh (-20.39%)
Chuck Royce 46,438 sh (-20.53%)
Jim Simons 33,650 sh (-25.96%)
» More
Q4 2014

CMN Guru Trades in Q4 2014

Ken Fisher 5,501 sh (New)
Ron Baron 605,100 sh (New)
Mario Gabelli 371,038 sh (-4.80%)
Chuck Royce 42,338 sh (-8.83%)
Joel Greenblatt 9,069 sh (-48.01%)
Jim Simons 15,100 sh (-55.13%)
» More
Q1 2015

CMN Guru Trades in Q1 2015

Ron Baron 700,000 sh (+15.68%)
Chuck Royce Sold Out
Ken Fisher Sold Out
Mario Gabelli 349,438 sh (-5.82%)
Joel Greenblatt 7,967 sh (-12.15%)
Jim Simons 9,300 sh (-38.41%)
» More
Q2 2015

CMN Guru Trades in Q2 2015

Ron Baron 700,000 sh (unchged)
Joel Greenblatt Sold Out
Jim Simons Sold Out
Mario Gabelli 309,338 sh (-11.48%)
» More
» Details

Insider Trades

Latest Guru Trades with CMN

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 45.50
CMN's P/E(ttm) is ranked lower than
74% of the 113 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 29.00 vs. CMN: 45.50 )
Ranked among companies with meaningful P/E(ttm) only.
CMN' s 10-Year P/E(ttm) Range
Min: 9.24  Med: 21.35 Max: 50.08
Current: 45.5
9.24
50.08
PE(NRI) 45.40
CMN's PE(NRI) is ranked lower than
78% of the 112 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 28.40 vs. CMN: 45.40 )
Ranked among companies with meaningful PE(NRI) only.
CMN' s 10-Year PE(NRI) Range
Min: 11.86  Med: 22.68 Max: 49.99
Current: 45.4
11.86
49.99
P/B 5.26
CMN's P/B is ranked lower than
76% of the 178 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.91 vs. CMN: 5.26 )
Ranked among companies with meaningful P/B only.
CMN' s 10-Year P/B Range
Min: 0.77  Med: 1.96 Max: 5.79
Current: 5.26
0.77
5.79
P/S 3.77
CMN's P/S is ranked lower than
59% of the 190 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.67 vs. CMN: 3.77 )
Ranked among companies with meaningful P/S only.
CMN' s 10-Year P/S Range
Min: 0.51  Med: 1.49 Max: 4.15
Current: 3.77
0.51
4.15
PFCF 47.53
CMN's PFCF is ranked lower than
75% of the 83 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 28.56 vs. CMN: 47.53 )
Ranked among companies with meaningful PFCF only.
CMN' s 10-Year PFCF Range
Min: 7.31  Med: 17.13 Max: 809.8
Current: 47.53
7.31
809.8
POCF 36.17
CMN's POCF is ranked lower than
76% of the 114 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 19.43 vs. CMN: 36.17 )
Ranked among companies with meaningful POCF only.
CMN' s 10-Year POCF Range
Min: 5.66  Med: 14.47 Max: 50.61
Current: 36.17
5.66
50.61
EV-to-EBIT 28.76
CMN's EV-to-EBIT is ranked lower than
70% of the 120 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 19.58 vs. CMN: 28.76 )
Ranked among companies with meaningful EV-to-EBIT only.
CMN' s 10-Year EV-to-EBIT Range
Min: 7.3  Med: 16.25 Max: 34.9
Current: 28.76
7.3
34.9
PEG 2.55
CMN's PEG is ranked higher than
58% of the 66 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.66 vs. CMN: 2.55 )
Ranked among companies with meaningful PEG only.
CMN' s 10-Year PEG Range
Min: 0.7  Med: 1.66 Max: 7.92
Current: 2.55
0.7
7.92
Shiller P/E 60.63
CMN's Shiller P/E is ranked lower than
81% of the 80 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 30.14 vs. CMN: 60.63 )
Ranked among companies with meaningful Shiller P/E only.
CMN' s 10-Year Shiller P/E Range
Min: 8.99  Med: 25.04 Max: 67.06
Current: 60.63
8.99
67.06
Current Ratio 2.74
CMN's Current Ratio is ranked higher than
60% of the 185 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.41 vs. CMN: 2.74 )
Ranked among companies with meaningful Current Ratio only.
CMN' s 10-Year Current Ratio Range
Min: 1.45  Med: 2.85 Max: 5.07
Current: 2.74
1.45
5.07
Quick Ratio 1.68
CMN's Quick Ratio is ranked higher than
54% of the 185 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.60 vs. CMN: 1.68 )
Ranked among companies with meaningful Quick Ratio only.
CMN' s 10-Year Quick Ratio Range
Min: 0.88  Med: 1.71 Max: 2.41
Current: 1.68
0.88
2.41
Days Inventory 74.96
CMN's Days Inventory is ranked higher than
81% of the 183 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 128.59 vs. CMN: 74.96 )
Ranked among companies with meaningful Days Inventory only.
CMN' s 10-Year Days Inventory Range
Min: 55.68  Med: 75.86 Max: 137.47
Current: 74.96
55.68
137.47
Days Sales Outstanding 49.08
CMN's Days Sales Outstanding is ranked higher than
76% of the 161 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 63.01 vs. CMN: 49.08 )
Ranked among companies with meaningful Days Sales Outstanding only.
CMN' s 10-Year Days Sales Outstanding Range
Min: 42.46  Med: 55.48 Max: 87.67
Current: 49.08
42.46
87.67

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 0.20
CMN's Dividend Yield is ranked lower than
94% of the 149 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.45 vs. CMN: 0.20 )
Ranked among companies with meaningful Dividend Yield only.
CMN' s 10-Year Dividend Yield Range
Min: 0.17  Med: 0.31 Max: 0.7
Current: 0.2
0.17
0.7
Dividend Payout 0.09
CMN's Dividend Payout is ranked higher than
97% of the 86 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.34 vs. CMN: 0.09 )
Ranked among companies with meaningful Dividend Payout only.
CMN' s 10-Year Dividend Payout Range
Min: 0.13  Med: 0.17 Max: 0.22
Current: 0.09
0.13
0.22
Dividend growth (3y) 19.30
CMN's Dividend growth (3y) is ranked higher than
80% of the 54 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9.20 vs. CMN: 19.30 )
Ranked among companies with meaningful Dividend growth (3y) only.
CMN' s 10-Year Dividend growth (3y) Range
Min: 0  Med: 0.00 Max: 19.3
Current: 19.3
0
19.3
Yield on cost (5-Year) 0.20
CMN's Yield on cost (5-Year) is ranked lower than
91% of the 152 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.61 vs. CMN: 0.20 )
Ranked among companies with meaningful Yield on cost (5-Year) only.
CMN' s 10-Year Yield on cost (5-Year) Range
Min: 0.17  Med: 0.31 Max: 0.7
Current: 0.2
0.17
0.7
Share Buyback Rate -2.10
CMN's Share Buyback Rate is ranked higher than
52% of the 132 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: -2.30 vs. CMN: -2.10 )
Ranked among companies with meaningful Share Buyback Rate only.
CMN' s 10-Year Share Buyback Rate Range
Min: -0.5  Med: -2.45 Max: -13.3
Current: -2.1

Valuation & Return

vs
industry
vs
history
Price/Tangible Book 33.27
CMN's Price/Tangible Book is ranked lower than
94% of the 157 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.27 vs. CMN: 33.27 )
Ranked among companies with meaningful Price/Tangible Book only.
CMN' s 10-Year Price/Tangible Book Range
Min: 1.61  Med: 5.87 Max: 71.15
Current: 33.27
1.61
71.15
Price/Projected FCF 2.40
CMN's Price/Projected FCF is ranked lower than
69% of the 95 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.76 vs. CMN: 2.40 )
Ranked among companies with meaningful Price/Projected FCF only.
CMN' s 10-Year Price/Projected FCF Range
Min: 0.59  Med: 1.29 Max: 5.04
Current: 2.4
0.59
5.04
Price/DCF (Earnings Based) 1.59
CMN's Price/DCF (Earnings Based) is ranked higher than
58% of the 19 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.72 vs. CMN: 1.59 )
Ranked among companies with meaningful Price/DCF (Earnings Based) only.
N/A
Price/Median PS Value 2.54
CMN's Price/Median PS Value is ranked lower than
93% of the 166 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.15 vs. CMN: 2.54 )
Ranked among companies with meaningful Price/Median PS Value only.
CMN' s 10-Year Price/Median PS Value Range
Min: 0.28  Med: 0.82 Max: 2.31
Current: 2.54
0.28
2.31
Price/Peter Lynch Fair Value 2.25
CMN's Price/Peter Lynch Fair Value is ranked lower than
58% of the 48 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.00 vs. CMN: 2.25 )
Ranked among companies with meaningful Price/Peter Lynch Fair Value only.
CMN' s 10-Year Price/Peter Lynch Fair Value Range
Min: 0.47  Med: 1.33 Max: 7.59
Current: 2.25
0.47
7.59
Price/Graham Number 8.22
CMN's Price/Graham Number is ranked lower than
94% of the 90 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.52 vs. CMN: 8.22 )
Ranked among companies with meaningful Price/Graham Number only.
CMN' s 10-Year Price/Graham Number Range
Min: 0.94  Med: 2.47 Max: 9.15
Current: 8.22
0.94
9.15
Earnings Yield (Greenblatt) (%) 3.50
CMN's Earnings Yield (Greenblatt) (%) is ranked higher than
55% of the 184 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.90 vs. CMN: 3.50 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
CMN' s 10-Year Earnings Yield (Greenblatt) (%) Range
Min: 2.9  Med: 6.15 Max: 13.7
Current: 3.5
2.9
13.7
Forward Rate of Return (Yacktman) (%) 22.10
CMN's Forward Rate of Return (Yacktman) (%) is ranked higher than
78% of the 92 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 12.13 vs. CMN: 22.10 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
CMN' s 10-Year Forward Rate of Return (Yacktman) (%) Range
Min: 10.4  Med: 20.10 Max: 29.6
Current: 22.1
10.4
29.6

Business Description

Industry: Medical Instruments & Equipment » Medical Instruments & Supplies
Compare:WST, BAX, COV, TMO, COO » details
Traded in other countries:CI2.Germany,
Cantel Medical Corp was incorporated in Delaware. The Company is a provider of infection prevention and control products in the healthcare market. Its operating segments include: Endoscopy, Water Purification and Filtration, Healthcare Disposables, Dialysis, and Specialty Packaging. Endoscopy segment offers medical device reprocessing systems, disinfectants, detergents and other supplies used to high-level disinfect flexible endoscopes. This segment also offers disposable infection control products intended to eliminate the challenges associated with proper cleaning and high-level disinfection of numerous reusable components used in gastrointestinal (GI) endoscopy procedures. Water Purification and Filtration segment offers water purification equipment and services, filtration and separation products, and disinfectants for the medical, pharmaceutical, biotech, beverage and commercial industrial markets. The healthcare Disposables segment offers single-use, infection prevention and control healthcare products used principally in the dental market including face masks, sterilization pouches, towels and bibs, tray covers, saliva ejectors, germicidal wipes, plastic cups and disinfectants. This segment also manufactures and provides biological and chemical indicators for sterility assurance monitoring services in the acute-care, alternate-care and dental markets. Dialysis segment offers medical device reprocessing systems, sterilants/disinfectants, dialysate concentrates and other supplies for renal dialysis. Specialty Packaging segment offers specialty packaging and thermal control products, as well as related compliance training, for the transport of infectious and biological specimens and thermally sensitive pharmaceutical, medical and other products. The Company sells and services its endoscope reprocessing equipment, high-level disinfectants, cleaners and consumables through its own United States field sales and service organization. Outside of the United States, it sells through independent distribution partners in Europe, Canada, Asia, Australia and Latin America as well as its own sales and service organizations in the Netherlands and Singapore. Its Competitors include Kimberly-Clark, 3M, Steris, Danaher/Sybron, Dentsply/Sultan Healthcare, Amcor. The Company's products are subject to regulation by the FDA, which regulates the testing, manufacturing, packaging, distribution and marketing of its medical devices and water purification devices in the United States.
» More Articles for CMN

Headlines

Articles On GuruFocus.com
Baron Small Cap Fund's Commentary on Cantel Medical Corp. Mar 19 2015 
Ron Baron's Top 5 New Holdings Feb 19 2015 
Small items not cut Mar 03 2013 
Cantel Medical Corp. (CMN) Sr. V.P., CFO and Treasurer Craig A Sheldon sells 2,607 Shares Mar 15 2011 
Cantel Medical Corp. Reports Operating Results (10-Q) Mar 11 2011 
Cantel Medical Corp. Reports Operating Results (10-Q) Dec 10 2010 
Cantel Medical Corp. Reports Operating Results (10-K) Oct 14 2010 
Cantel Medical Corp. Reports Operating Results (10-Q) Jun 09 2010 
Cantel Medical Corp. (CMN) President and CEO Andrew A Krakauer sells 11,505 Shares Apr 09 2010 
Cantel Medical Corp. (CMN) Chairman, 10% Owner Charles M Diker buys 5,000 Shares Oct 26 2009 

More From Other Websites
Cantel Medical Appoints David Rosen as President, Asia Pacific and Emerging Markets Aug 07 2015
Cantel Medical Appoints David C. Hemink as President, Medivators and Michael G. Spicer as President,... Jun 29 2015
Edited Transcript of CMN earnings conference call or presentation 9-Jun-15 3:00pm GMT Jun 27 2015
Edited Transcript of CMN presentation 1-Jun-15 6:30pm GMT Jun 26 2015
CANTEL MEDICAL CORP Files SEC form 8-K, Change in Directors or Principal Officers Jun 19 2015
Cantel Medical Board Of Directors Authorizes Regular Semiannual Dividend Jun 18 2015
CANTEL MEDICAL CORP Financials Jun 12 2015
10-Q for Cantel Medical Corp. Jun 11 2015
Cantel Medical Q3 Earnings, Sales Rise Y/Y; Outlook Positive - Analyst Blog Jun 10 2015
CANTEL MEDICAL CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Jun 09 2015
Cantel posts 3Q profit Jun 09 2015
Cantel posts 3Q profit Jun 09 2015
Cantel Medical Reports Results For The Third Quarter Ended April 30, 2015 Jun 09 2015
Q3 2015 Cantel Medical Corp Earnings Release - Before Market Open Jun 09 2015
Cantel Medical Corp. to Host Third Quarter 2015 Earnings Conference Call and Webcast Live on... Jun 08 2015
Cantel Medical Corp. To Hold Conference Call To Discuss Results For Its Third Quarter Ended April... Jun 01 2015
Cantel Medical To Present At The Jefferies 2015 Global Healthcare Conference May 19 2015
Cantel Medical To Present At The Bank Of America Merrill Lynch Healthcare Conference May 01 2015
CANTEL MEDICAL CORP Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits Apr 30 2015
CANTEL MEDICAL CORP Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits Apr 15 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK